Jacob Thaysen

Chief Executive Officer at ILLUMINA, INC.

Net worth: 7 M $ as of 31/05/2026

51 year

67 connections

Health Technology

Electronic Technology

Commercial Services

Profile

Jacob Thaysen is the founder of Cantion A. Dr. Thaysen is currently Chairman at Analytical Life Science & Diagnostics Association, Director, Chief Executive & Commercial Officer at Illumina, Inc. since 2023, Director at Lasergen, Inc., and Member of the American Cancer Society's CEOs Against Cancer.
Formerly, Dr. Thaysen was Director at Gen9, Inc., SVP & President-Life Sciences & Applied Markets at Agilent Technologies, Inc. from 2018 to 2023, Vice President-Research & Development at Cytologix Corp., and Vice President-System Development, R&D at Dako Denmark ApS from 2012 to 2013.
Education includes graduate and doctorate degrees from the Technical University of Denmark, conferred in 1998 and 2001 respectively.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ILLUMINA, INC. 0.03%	26/03/2026	40,313 ( 0.03% )	7 M $	31/05/2026

Latest news about Jacob Thaysen

01/25/01

'Hopeful' We'll Find Long-term Solution On China: Illumina CEO

Jacob Thaysen active positions

Companies	Position	Start
ILLUMINA, INC.	Chief Executive Officer	25/09/2023
Lasergen, Inc. Lasergen, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets measurement and monitoring instruments	Director/Board Member	-
Analytical Life Science & Diagnostics Association	Chairman	-
American Cancer Society's CEOs Against Cancer	Corporate Officer/Principal	-

All active positions of Jacob Thaysen

Former positions of Jacob Thaysen

Companies	Position	End
AGILENT TECHNOLOGIES, INC.	Corporate Officer/Principal	05/09/2023
Cytologix Corp. Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes automation technology for slide-based cellular diagnostics	Chief Tech/Sci/R&D Officer	18/05/2011
Cantion A/S Cantion A/S Electronic Equipment/InstrumentsElectronic Technology Manufactures measuring and testing equipment	Founder	-
Gen9, Inc. Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies	Director/Board Member	-
Dako Denmark ApS Dako Denmark ApS Medical SpecialtiesHealth Technology Designs and manufactures cancer diagnostic systems	Chief Tech/Sci/R&D Officer	-

See the detail of Jacob Thaysen's experience

Training of Jacob Thaysen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jacob Thaysen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Agilent Technologies, Inc. Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets	Health Technology
Illumina, Inc. Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments	Health Technology
Gen9, Inc. Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies	Health Technology
Cytologix Corp. Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes automation technology for slide-based cellular diagnostics	Commercial Services
Dako Denmark ApS Dako Denmark ApS Medical SpecialtiesHealth Technology Designs and manufactures cancer diagnostic systems	Health Technology
Technical University of Denmark Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cantion A/S Cantion A/S Electronic Equipment/InstrumentsElectronic Technology Manufactures measuring and testing equipment	Electronic Technology
Lasergen, Inc. Lasergen, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures and markets measurement and monitoring instruments	Electronic Technology
American Cancer Society's CEOs Against Cancer
Analytical Life Science & Diagnostics Association